How does too much LDL or ApoB lead to clogged arteries?
Too many LDL and apoB particles sets off a well-established chain reaction that gradually clogs arteries. Having your apoB level measured gives your doctor a more accurate picture of your true risk than LDL cholesterol alone.
LDL particles penetrate the inner wall of arteries and become trapped there by scaffolding molecules in the tissue. The protein apoB on each LDL particle attaches to those scaffolding molecules. This causes particles to accumulate in the vessel wall, even when they are not 'requested'. The more particles circulating in the blood, the more often this happens.
Once lodged in the wall, those LDL particles undergo chemical changes. They release fatty substances that trigger inflammation in the vessel cells, and that inflammation in turn attracts immune cells. In this way, an excess of LDL sets off a self-reinforcing chain reaction.
The incoming immune cells attempt to engulf the modified LDL particles. They succeed in doing so, but become overloaded with fat and turn into so-called 'foam cells'. These foam cells eventually die because they cannot handle that fat burden. The accumulation of dead cells and crystallised cholesterol forms the most dangerous layer of a plaque, known as the necrotic core. If that ruptures, a blood clot can cause a heart attack or stroke.
Every atherogenic particle, LDL but also VLDL and so-called remnant particles, carries exactly one apoB molecule. The number of apoB molecules in your blood therefore indicates precisely how many of those dangerous particles are circulating. This makes apoB more accurate than standard LDL cholesterol, which only measures the amount of fat inside the particles. Two people with the same LDL cholesterol can have vastly different numbers of particles and therefore vastly different risks. European cardiology guidelines consequently regard apoB as the superior risk marker.
Remnant particles (the leftovers of fat-rich lipoproteins after processing) deserve special attention. In a study of more than 17,000 people without known heart disease, high remnant cholesterol levels raised the risk of a cardiovascular event by 65 percent, even after correcting for both LDL and apoB. They appear to cause damage through their own mechanisms, most likely because their high triglyceride content provokes additional inflammation in the vessel wall.
All mechanistic steps are based on strong evidence from multiple studies (PMID 39743565, 36216435, 34625741). The remnant finding (PMID 34293083, 41701506) is based on large observational data but does not yet have definitive causal proof in humans. HELZ2 and vaccine therapies have so far been studied exclusively in animals or preclinically and have been left out of the main text because they do not directly answer the reader's question.
Is ApoB more important than regular cholesterol (LDL)?
ApoB consistently predicts cardiovascular disease better than LDL cholesterol. If you want to know how high your risk truly is, ask your doctor to measure ApoB alongside the standard cholesterol panel.
How do you lower an ApoB level that is too high?
An ApoB level that is too high is very treatable, and several proven agents are available. Statins are the first choice; PCSK9 inhibitors offer the strongest reduction when statins are insufficient or not tolerated.
What does a low-carbohydrate diet do to your LDL cholesterol in the long term?
A low-carbohydrate diet raises LDL in the short term, but that effect often disappears after a year; the effect on triglycerides and HDL is more favourable, but what this means for your long-term heart disease risk has not yet been proven.
What does your ApoB value tell you about your risk of cardiovascular disease?
ApoB gives a more accurate picture of your cardiovascular disease risk than standard LDL cholesterol. Ask your doctor to also measure ApoB (and possibly Lp(a)), especially if you have doubts about your risk profile.
Who should have their ApoB measured?
Measuring ApoB is worthwhile for more people than current guidelines suggest: not only in cases of elevated blood fats, but also with excess weight, diabetes, familial hypercholesterolaemia, women after menopause, and people already taking cholesterol-lowering medication.
How early in life should you start lowering your LDL cholesterol to prevent cardiovascular disease?
Starting as early as possible pays off: LDL damage accumulates from childhood, and every year that your LDL remains lower counts. If familial high cholesterol runs in your family, discuss with your doctor whether screening from a young age makes sense.